Medicines Formulary

Medicines A–Z

T

Drug name	NICE TAs	Comments
Tisseel		Hospital use only
Tivozanib	TA512 - Tivozanib for treating advanced renal cell carcinoma
Tizanidine tablets
Tobradex eye drops
Tobramycin nebulised		NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013
Tobramycin nebulised		NHS England Commissioned for Cystic Fibrosis only, new patients
Tocilizumab (Tyenne® Roactemra®)	TA247 - Rheumatoid arthritis - tocilizumab (rapid review TA198) TA238 - Tocilizumab for the treatment of systemic juvenile idiopathic arthritis TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA373 - Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis	Hospital use only
Tofacitinib (Xeljanz®)	TA480 - Tofacitinib for moderate to severe rheumatoid arthritis TA543 - Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs TA735 - Tofacitinib for treating juvenile idiopathic arthritis TA920 - Tofacitinib for treating active ankylosing spondylitis
Tofacitinib (Xeljanz®)	TA547 - Tofacitinib for moderately to severely active ulcerative colitis
Tolterodine M/R capsules		High relative cost. Second line.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.